Barclays lowered the firm’s price target on McCormick (MKC) to $82 from $85 and keeps an Equal Weight rating on the shares. While McCormick moderated the low end of its fiscal 2025 organic sales growth range likely due to a slower recovery in China, the company’s Q4 sales momentum in its consumer segment “should carry the day” with respect to near-term relative share performance, the analyst tells investors in a research note.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MKC:
- MKC Earnings: Frank’s RedHot Sauce Maker McCormick Not Dining Out on China Sales
- McCormick price target lowered to $85 from $95 at Argus
- McCormick & Company Reports Strong 2024 Financial Performance
- EA cuts FY25 bookings guide, American Air reports Q4 beat: Morning Buzz
- Morning Movers: GE Aerospace climbs after fourth quarter results